Cd38 as a biomarker and biotarget in cell-lymphomas

Lorem ipsum

Keywords: liste keywords
Patent Application number: European Procedure (Patents) (EPA) - 31 Janv. 2022 - 22 305 106.1
Inventors:
Liste inventeurs
Publications:
Pub scient Lorem ipsum

Reference:

BIO22037-R1

Business Developper
contact
Inserm Transfert Flowline
Inserm Transfert Flowline
Business Developer
Patent filling date: 2024-02-06
Rare disease: Yes
Second indication: Yes

You might also be interested in